Search results
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
How can companies address consumers who are averse to products using a novel technology?
Phys.org· 7 days agoThe study, which appears in the Journal of Marketing, is titled "Adoption of New Technology...
The Path to a Better Tuberculosis Vaccine Runs Through Montana
US News & World Report· 5 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The ...
The Path to a Better Tuberculosis Vaccine Runs Through Montana
North Denver News· 5 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The ...
COVID-19 On Steep Decline, But Physicians Advise Public To Continue Vaccines
Houston Press· 7 days agoTexas is entering into the spring season in a good spot in terms of the number of cases, emergency room visits, hospital admissions and deaths due to COVID-19, which are all steadily declining ...